NF-κB p65 Antagonizes IL-4 Induction by c-maf in Minimal Change Nephrotic Syndrome

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 688-698

  Valanciuté, Asta ^a   Le Gouvello, Sabine ^a   Solhonne, Brigitte ^a   Pawlak, André ^a   Grimbert, Philippe ^a   Lyonnet, Luc ^a   Hue, Sophie ^a   Lang, Philippe ^a   Remy, Philippe ^a   Salomon, Rémy ^b   Bensman, Albert ^c   Guellaën, Georges ^a   Sahali, Djillali ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MESSENGER RNA; PROTEASOME; SYNAPTOTAGMIN;

ADOLESCENT; ADULT; ARTICLE; BINDING SITE; CELL COMPARTMENTALIZATION; CELL ONCOGENE; CELLULAR IMMUNITY; CHILD; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; FEMALE; GENE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; IL4 GENE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

EID: 9144227668     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.688     Document Type: Article

References (33)

1. Niaudet, P. 1993. Nephrotic syndrome in children. Curr. Opin. Pediatr. 5:174.
2. Michael, A. F., R. H. McLean, L. P. Roy, N. G. Westberg, J. R. Hoyer, A. J. Fish, and R. L. Vernier. 1973. Immunologic aspects of the nephrotic syndrome. Kidney Int. 3:105.
3. Glassock, R. J., S. G. Adler. H. J. Ward, and A. H. Cohen. 1991. Minimal change disease in primary glomerular diseases. In The Kidney, 4th Ed., Vol. 1. B. M. Brenner and F. C. Rector, eds. Saunders, Philadelphia, p. 1224.
4. Schnaper, H. W. 1989. The immune system in minimal change nephrotic syndrome. Pediatr. Nephrol. 3:101.
5. Boulton Jones, J. M., I. Tulloch, B. Dore, and A. McLay. 1983. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin. Nephrol. 20:72.
6. Yoshizawa, N., Y. Kusumi, K. Matsumoto, S. Oshima, A. Takeuchi, O. Kawamura, T. Kubota, S. Kondo, and H. Niwa. 1989. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron. 51:370.
7. Tanaka, R., N. Yoshikawa, H. Nakamura, and H. Ito. 1992. Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron. 60:35.
8. Sahali, D., A. Pawlak, A. Valanciute, P. Grimbert, P. Lang, P. Remy, A. Bensman, and G. Guellen. 2002. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J. Am. Soc. Nephrol. 13:1238.
9. Kimata, H., M. Fujimoto, and K. Furusho. 1995. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur. J. Immunol. 25:1497.
10. Yap, H. K., W. Cheung, B. Murugasu, S. K. Sim, C. C. Seah, and S. C. Jordan. 1999. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J. Am. Soc. Nephrol. 10:529.
11. Fodor, P., M. T. Saitua, E. Rodriguez, B. Gonzalez, and L. Schlesinger. 1982. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am. J. Dis. Child. 136:713.
12. Blank, V., and N. C. Andrews. 1997. The Maf transcription factors: regulators of differentiation. Trends Biochem. Sci. 22:437.
13. Chesi, M., P. L. Bergsagel, O. O. Shonukan, M. L. Marielli, L. A. Brents, T. Chen, E. Schrock, T. Ried, and W. M. Kuehl. 1998. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457.
14. Kataoka, K., M. Noda, and M. Nishizawa. 1994. Maf nuclear oncoprotein recognizes sequences related to an AP-I site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol. 14:700.
15. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
16. Ho, I. C., and L. H. Glimcher. 2002. Transcription: tantalizing times for T cells. Cell 109:S109.
17. Kim, J. I., T. Li, I. C. Ho, M. J. Grusby, and L. H. Glimcher. 1999. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc. Natl. Acad. Sci. USA 96:3781.
18. Ranganath, S., and K. M. Murphy. 2001. Structure and specificity of GATA proteins in Th2 development. Mol. Cell. Biol. 21:2716.
19. Sahali, D., A. Pawlak, S. Le Gouvello, P. Lang, A. Valanciute, P. Remy, C. Loirat, P. Niaudet, A. Bensman, and G. Guellaen. 2001. Transcriptional and post-transcriptional alterations of IκBα in active minimal-change nephrotic syndrome. J. Am. Soc. Nephrol. 12:1648.
20. Anonymous. 1981. The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisone: a report of the International Study of Kidney Disease in Children. J. Pediatr. 98:561.
21. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71:777.
22. Chen, Q., D. H. Dowhan, D. Liang, D. D. Moore, and P. A. Overbeek. 2002. CREB-binding protein/p300 co-activation of crystallin gene expression. J. Biol. Chem. 277:24081.
23. Philipsen, S., and G. Suske. 1999. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27:2991.
24. Hedge, S. P., A. Kumar, C. Kurschner, and L. H. Shapiro. 1998. c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Mol. Cell. Biol. 18:2729.
25. Daniel, V., Y. Trautmann, M. Konrad, A. Nayir, and K. Scharer. 1997. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin. Nephrol. 47:289.
26. Koyama, A., M. Fujisaki, M. Kobayashi, M. Igarashi, and M. Narita. 1991. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 40:453.
27. Hulton, S. A., T. J. Neuhaus, R. E. Callard, M. J. Dillon, and T. M. Barratt. 1997. Circulating interleukin 2 receptor (IL-2R) in nephrotic syndrome. Kidney Int. Suppl. 58:S83.
28. Grimbert, P., A. Valanciute, V. Audard, A. Pawlak, S. Le Gouvelo, P. Lang, P. Niaudet, A. Bensman, G. Guellaen, and D. Sahali. 2003. Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J. Exp. Med. 198:797.
29. Cao, S., J. Liu, M. Chesi, P. L. Bergsagel, I. C. Ho, R. P. Donnelly, and X. Ma. 2002. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 169:5715.
30. Ho, I. C., D. Lo, and L. H. Glimcher. 1998. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188:1859.
31. Almawi, W. Y., and O. K. Melemedjian. 2002. Negative regulation of nuclear factor-κB activation and function by glucocorticoids. J. Mol. Endocrinol. 28:69.
32. Das, J., C. H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray. 2001. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45.
33. Kishikawa, H., J. Sun, A. Choi, S. C. Miaw, and I. C. Ho. 2001. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J. Immunol. 167:4414.